Advertisement
No access
Reports

Cross Talk Between Interferon-γ and -α/β Signaling Components in Caveolar Membrane Domains

Science
30 Jun 2000
Vol 288, Issue 5475
pp. 2357-2360

Abstract

Definition of cellular responses to cytokines often involves cross-communication through their respective receptors. Here, signaling by interferon-γ (IFN-γ) is shown to depend on the IFN-α/β receptor components. Although these IFNs transmit signals through distinct receptor complexes, the IFN-α/β receptor component, IFNAR1, facilitates efficient assembly of IFN-γ–activated transcription factors. This cross talk is contingent on a constitutive subthreshold IFN-α/β signaling and the association between the two nonligand-binding receptor components, IFNAR1 and IFNGR2, in the caveolar membrane domains. This aspect of signaling cross talk by IFNs may apply to other cytokines.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (1049334.xhtml)
File (1049334s1_large.jpeg)
File (1049334s1_med.gif)
File (1049334s1_thumb.gif)
File (1049334s2_large.jpeg)
File (1049334s2_med.gif)
File (1049334s2_thumb.gif)
File (1049334s3._thumb.gif)
File (1049334s3_med.gif)
File (1049334s3_thumb.gif)
File (1049334s4_med.gif)
File (1049334s4_thumb.gif)
File (1049334s5_large.jpeg)
File (1049334s5_med.gif)
File (1049334s5_thumb.gif)

REFERENCES AND NOTES

1
Weissmann C., Weber H., Prog. Nucleic Acid Res. Mol. Biol. 33, 251 (1986).
2
E. DeMaeyer and J. DeMaeyer-Guignard, Interferons and Other Regulatory Cytokines (Wiley, New York, 1988).
3
J. Vilcek and G. S. Sen, in Fields Virology, D. M. Fields, P. M. Knipe, P. M. Howley, Eds. (Lippincott-Raven, Philadelphia, ed. 3, 1996), p. 375.
4
Pestka S., Langer J. A., Zoon K. C., Samuel C. E., Annu. Rev. Biochem. 56, 727 (1987).
5
Billiau A., Adv. Immunol. 62, 61 (1996).
6
Schindler C., Darnell J. E., Annu. Rev. Biochem. 64, 621 (1995).
7
Bach E. A., Aguet M., Schreiber R. D., Annu. Rev. Immunol. 15, 563 (1997).
8
Stark G. R., Kerr I. M., Williams B. R., Silverman R. H., Schreiber R. D., Annu. Rev. Biochem. 67, 227 (1998).
9
Darnell J. E., Kerr I. M., Stark G. R., Science 264, 1415 (1994).
10
Ihle J. N., Kerr I. M., Trends Genet. 11, 69 (1995).
11
Bluyssen A. R., Durbin J. E., Levy D. E., Cytokine Growth Factor Rev. 7, 11 (1996).
12
The result of the antiviral assay presented in figure 2A of U. Müller et al. [Science 264, 1918 (1994)] is consistent with our present results. To investigate further the extent to which the loss of IFNAR1 affects IFN-γ–induced gene expression, we examined the mRNA induction kinetics for IRF-1 and 2′,5′OAS genes by IFN-γ in the WT and IFNAR1-null MEFs. The induction of IRF-1 mRNA by IFN-γ was six times lower in the mutant MEFs than in the WT MEFs. We also examined the induction of 2′,5′OAS mRNA, which is dependent on ISGF3, in the WT and IFNAR1-null MEFs. The induction of 2′,5′OAS mRNA by IFN-γ remained undetectable in IFNAR1-null MEFs throughout the time course tested (19).
13
S. Huang et al., Science 259, 1742 (1993).
14
IFNAR1-deficient and IFNGR1-deficient mice were purchased from B&K Universal Group (North Humberside, UK). MEFs and splenocytes were prepared according to standard methods [
Takaoka A., et al., EMBO J. 18, 2480 (1999);
]. Recombinant murine IFN-γ was purchased from Genzyme/Techne.
15
Flow cytometry and immunoblot analyses revealed that the expression levels of IFNGR1 and IFNGR2 in these cells are essentially the same as in the WT MEFs. Immunoblot analysis showed that nearly the same amount of endogenous Stat1 protein was detected in the WT and IFNAR1-null MEFs.
16
A. Takaoka and Y. Mitani, unpublished data.
17
M. Matsumoto et al., Biol. Chem.380, 699 (1999).
18
T. Kimura et al., Genes Cells1, 115 (1996).
19
Supplemental Web material is available at Science Online at www.sciencemag.org/feature/data/1049334.shl.
20
M. Sato, unpublished results.
21
L. Erlandsson et al., Curr. Biol.8, 223 (1998).
22
K. Shuai et al., Cell 76, 821 (1994).
23
Li X., Leung S., Kerr I. M., Stark G. R., Mol. Cell. Biol. 17, 2048 (1997).
24
H. Yan et al., EMBO J. 15, 1064 (1996).
25
Greenlund A. C., Farrar M. A., Viviano B. L., Schreiber R. D., EMBO J. 13, 1591 (1994).
26
Fleischmann W. R., Georgiades J. A., Osborne L. C., Johnson H. M., Infect. Immun. 26, 248 (1979).
27
Stewart W. E., Gosser L. B., Lockart R. Z., J. Virol. 7, 792 (1971).
28
Simons K., Ikonen E., Nature 387, 569 (1997).
29
Xavier R., Brennan T., Li Q., McCormack C., Seed B., Immunity 8, 723 (1998).
30
Detergent-free caveolae fractions were prepared as described [
Smart E. J., Ying Y. S., Mineo C., Anderson R. G., Proc. Natl. Acad. Sci. U.S.A. 92, 10104 (1995);
Mineo C., James G. L., Smart E. J., Anderson R. G., J. Biol. Chem. 271, 11930 (1996);
]. The reversibility of the effects of filipin treatment was investigated as described [
Schnitzer J. E., Oh P., Pinney E., Allard J., J. Cell. Biol. 127, 1217 (1994);
Xavier R., Brennan T., Li Q., McCormack C., Seed B., Immunity 8, 723 (1998);
]. Briefly, MEFs treated with filipin (Sigma) for 10 min were washed, incubated for 60 min in Dulbecco's modified Eagle's medium containing 20% fetal calf serum, and then stimulated with IFN-γ.
31
M. Sato et al., FEBS Lett.441, 106 (1998).
32
A. Takaoka et al., EMBO J.18, 2480 (1999).
33
Preparation of whole-cell extracts, binding reactions, and gel electrophoresis were done as described [
Takaoka A., et al., EMBO J. 18, 2480 (1999);
]. Unless otherwise noted, cells were treated with IFN-γ (250 U/ml) for 30 min. Equal amounts of proteins from whole-cell extracts were loaded onto each lane. Experiments were done in triplicate and were performed separately with at least two independent clones of MEFs derived from the same littermates of the WT or mutant mice.
34
After the treatment with IFN-γ (250 U/ml) for 15 min, cell lysis, immunoprecipitation, and immunoblotting were done as described [
Takaoka A., et al., EMBO J. 18, 2480 (1999);
]. The following antibodies were purchased: anti-phosphotyrosine, anti-Jak1, and anti-Jak2 (Upstate Biotechnology); anti-Stat1 p84/p91 and anti-Stat2 (Santa Cruz); anti-phosphorylated Stat1 (Tyr701) (New England BioLabs); anti-IFNAR1, anti-IFNGR1, and anti-IFNGR2 (Research Diagnostics); and anti-caveolin (Transduction Laboratories).
35
We thank G. Uzé for the murine IFNAR1 cDNA (GenBank accession number ); J. Vilcek and E. L. Barsoumian for invaluable advice; M. Asagiri, N. Hata, Y. Kato, and S. H. Kim for technical support; Sumitomo Pharmaceuticals for purified murine IFN-α; and Toray Industries for recombinant murine IFN-β. Animal care was in accordance with institutional guidelines of the University of Tokyo. Supported by grants from the Research for the Future Program (96L00307), Yamanouchi Foundation for Research on Metabolic Disorders, the Japan Society for the Promotion of Science, Advanced Research on Cancer, and the Human Frontier Science Program Organization.

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 288 | Issue 5475
30 June 2000

Submission history

Received: 9 February 2000
Accepted: 2 May 2000
Published in print: 30 June 2000

Permissions

Request permissions for this article.

Authors

Affiliations

Akinori Takaoka
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan.
Yukiko Mitani
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan.
Hirofumi Suemori
Meiji Institute of Health Science, Meiji Milk Products, Naruda 540, Odawara-shi, Kanagawa 250-0862, Japan.
Mitsuharu Sato
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan.
Taeko Yokochi
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan.
Shigeru Noguchi
Meiji Institute of Health Science, Meiji Milk Products, Naruda 540, Odawara-shi, Kanagawa 250-0862, Japan.
Nobuyuki Tanaka
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan.
Tadatsugu Taniguchi*
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan.

Notes

*
To whom correspondence should be addressed. E-mail: [email protected]

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. Interferons Horizon Therapeutics, Basic and Clinical Aspects of Interferon Gamma, (2022).https://doi.org/10.5772/intechopen.104718
    Crossref
  2. ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling, The Journal of Immunology, 208, 1, (74-84), (2022).https://doi.org/10.4049/jimmunol.2100742
    Crossref
  3. When does hepatitis B virus meet long-stranded noncoding RNAs?, Frontiers in Microbiology, 13, (2022).https://doi.org/10.3389/fmicb.2022.962186
    Crossref
  4. Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection, Frontiers in Immunology, 13, (2022).https://doi.org/10.3389/fimmu.2022.982264
    Crossref
  5. Post-transcriptional regulatory feedback encodes JAK-STAT signal memory of interferon stimulation, Frontiers in Immunology, 13, (2022).https://doi.org/10.3389/fimmu.2022.947213
    Crossref
  6. SRSF1 acts as an IFN-I-regulated cellular dependency factor decisively affecting HIV-1 post-integration steps, Frontiers in Immunology, 13, (2022).https://doi.org/10.3389/fimmu.2022.935800
    Crossref
  7. From bats to pangolins: new insights into species differences in the structure and function of the immune system, Innate Immunity, 28, 3-4, (107-121), (2022).https://doi.org/10.1177/17534259221093120
    Crossref
  8. Inhibitory and Injury-Protection Effects of O-Glycan on Gastric Epithelial Cells Infected with Helicobacter pylori, Infection and Immunity, 90, 10, (2022).https://doi.org/10.1128/iai.00393-22
    Crossref
  9. Interferon Alpha, but Not Interferon Beta, Acts Early To Control Chronic Chikungunya Virus Pathogenesis, Journal of Virology, 96, 1, (2022).https://doi.org/10.1128/JVI.01143-21
    Crossref
  10. Influenza A pathway analysis of highly pathogenic avian influenza virus (H5N1) infection in genetically disparate Ri chicken lines, Veterinary Immunology and Immunopathology, 246, (110404), (2022).https://doi.org/10.1016/j.vetimm.2022.110404
    Crossref
  11. See more
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Register for free to read this article

As a service to the community, this article is available for free. Login or register for free to read this article.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Full Text

FULL TEXT

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media